Premera · Wegovy · Varies by plan · Verified June 2026

Does Premera Blue Cross cover Wegovy?

It depends on your plan. Premera covers Wegovy for obesity with prior authorization, but only on plans where the employer elected the weight-loss drug benefit. A large share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. This is per Premera Blue Cross Pharmacy Policy 5.01.621, Drugs for Weight Management, verified June 12, 2026.

Coverage at a glance

IndicationCoverage
Obesity / chronic weight managementCovered with PA
Cardiovascular risk reduction (SELECT indication)Covered with PA

Plan type: Commercial and Medicare Advantage. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.

This varies by plan. Weight-loss drug coverage at Premera is employer-elected, not a default benefit. A significant share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. The pharmacy benefit manager for most Premera commercial plans is Express Scripts.

Coverage by indication

Obesity / chronic weight management · Covered with PA
BMI thresholdBMI 30 or higher, or BMI 27 or higher with a comorbidity, per the policy 5.01.621 criteria
Step therapyStep therapy through phentermine or orlistat may apply to some plan designs. Six months of documented lifestyle change is required.

What the prior authorization needs:

  • Your employer group must have elected the weight-loss drug benefit, which base plans do not include
  • Prior authorization is required on all qualifying plans
  • Six months of documented lifestyle intervention
  • Updated quantity limits took effect January 1, 2026

Policy 5.01.621. Source: Premera Blue Cross Pharmacy Policy 5.01.621, Drugs for Weight Management. Official payer medical policy PDF (public URL, binary; policy number confirmed by search-result title). Verified June 12, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.

Cardiovascular risk reduction (SELECT indication) · Covered with PA
BMI thresholdBMI 27 or higher with established cardiovascular disease
Cardiovascular criteriaPrior cardiovascular disease documented per the SELECT trial enrollment criteria
Step therapyNon-formulary on most plans. The standard formulary exception process is required.

What the prior authorization needs:

  • Formulary exception request through the standard process
  • Medicare Advantage pathway: CMS policy allows coverage when a medically accepted indication beyond weight loss exists

Source: Premera Providers, Wegovy Coverage with the New Cardiovascular Indication. Official payer provider news page (HTML, fetched directly). Verified June 12, 2026.

What to do next

If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list, then have your prescriber submit it.

  • Start with the Premera prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
  • Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
  • Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
  • If your plan does not cover the indication you need, compare cash-pay options in the cost guide and the cheapest legitimate programs.

Frequently asked questions

Does Premera cover Wegovy?

It depends on your plan. Premera covers Wegovy for obesity with prior authorization, but only on plans where the employer elected the weight-loss drug benefit. A large share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. This reflects the published policy verified June 2026.

What does Premera require to approve Wegovy?

For obesity / chronic weight management: The BMI requirement is BMI 30 or higher, or BMI 27 or higher with a comorbidity, per the policy 5.01.621 criteria. Step therapy through phentermine or orlistat may apply to some plan designs. Six months of documented lifestyle change is required.

Why might Premera deny Wegovy even if I meet the criteria?

Weight-loss drug coverage at Premera is employer-elected, not a default benefit. A significant share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. The pharmacy benefit manager for most Premera commercial plans is Express Scripts.

Coverage for other payers

See the full payer coverage index for every plan we have sourced.

Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources and the row is marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit, so those rows say varies by plan rather than a flat yes.

This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.